Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of ...

A study from National Taiwan University Hospital has unveiled how metabolic dysfunction significantly influences the ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis D, but it's pausing further development in ...

In a groundbreaking initiative, a pilot project for Hepatitis B (HBsAg) and Hepatitis C (HCV) screening has been launched in the remote district of Nagar, Skardu.This project marks a significant ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

The report provides a comprehensive analysis of global trends, challenges, and emerging opportunities in the Hepatitis B clinical research ecosystem. The report leverages Novotech’s extensive ...

Toronto Public Health warns 2,500 women about potential exposure to HIV, hepatitis B, and hepatitis C due to improper ...